Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Hello, everyone, and thank you for joining us today at the Goldman Sachs Global Healthcare Conference. We are so pleased to be joined by Jean-Marc Bellemin and Friedrich Finckenstein from Iovance Biotherapeutics to give us an update on where things are and where things are headed through the rest of 2021.
Questions & Answers
So to begin, let's start with the discussion of Iovance's core technology, which is a cell therapy technology called tumor-infiltrating lymphocytes or TILs. So at kind of first pass, can we start at a big picture level describing what TILs are and how they're employed as a therapeutic by Iovance?
Sure. Thank you, Madhu. I would like to give an introduction of Iovance, and again, thank you for hosting us at the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
